Education
About Us
Working with TipRanks
Follow Us
Zevra Therapeutics (ZVRA)
NASDAQ:ZVRA
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 23.61M | $ 27.46M | $ 10.16M | $ 28.65M | $ 13.29M |
| Gross Profit | $ 16.20M | $ 24.52M | $ 9.94M | $ 26.59M | $ 11.98M |
| Operating Income | $ -87.00M | $ -49.60M | $ -42.56M | $ 7.73M | $ -5.61M |
| EBITDA | $ -76.40M | $ -43.54M | $ -25.53M | $ -7.89M | $ -5.43M |
| Net Income | $ -105.51M | $ -46.05M | $ -26.77M | $ -8.55M | $ -12.76M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 69.50M | $ 67.74M | $ 82.85M | $ 112.35M | $ 4.21M |
| Total Assets | $ 178.13M | $ 172.33M | $ 115.53M | $ 132.94M | $ 11.21M |
| Total Debt | $ 60.30M | $ 43.77M | $ 14.12M | $ 1.61M | $ 70.35M |
| Net Debt | $ 26.51M | $ 716.00K | $ -51.34M | $ -110.76M | $ 66.14M |
| Total Liabilities | $ 138.46M | $ 110.46M | $ 40.22M | $ 5.82M | $ 77.62M |
| Stockholders' Equity | $ 39.67M | $ 61.86M | $ 75.12M | $ 127.12M | $ -66.41M |
| Cash Flow | |||||
| Free Cash Flow | $ -69.67M | $ -33.83M | $ -18.81M | $ 10.34M | $ -1.97M |
| Operating Cash Flow | $ -69.67M | $ -33.53M | $ -18.72M | $ 10.44M | $ -1.94M |
| Investing Cash Flow | $ -22.16M | $ -17.39M | $ -36.72M | $ -15.52M | $ -33.00K |
| Financing Cash Flow | $ 82.11M | $ 28.46M | $ 8.35M | $ 113.11M | $ 2.74M |